8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 13, 2008

HILLENBRAND INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)

Indiana	1-6651	35-1160484
(State or other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1069 State Route 46 East Batesville, Indiana	47006-8835
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (812) 934-7000

Not Applicable

(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01. Regulation FD Disclosure.

In connection with the previously announced anticipated distribution by Hillenbrand Industries, Inc. of all of the shares of Batesville Holdings, Inc. to Hillenbrand Industries’ shareholders, Hillenbrand Industries and Batesville Holdings have prepared investor presentations containing information about the two separate companies that will result from the distribution. These investor presentations are furnished as Exhibits 99.A and 99.B hereto and incorporated herein by reference. The investor presentations refer to the separated companies using the new names for the companies that will take effect prior to the completion of the distribution: Hill-Rom Holdings, Inc. (Hillenbrand Industries) and Hillenbrand, Inc. (Batesville Holdings).

Additionally, on March 13, 2008, Hillenbrand Industries issued a press release announcing the public availability of the investor presentations referred to above and providing financial guidance for fiscal 2008 for each of the two separate companies that will result from the distribution. This press release is furnished as Exhibit 99.C hereto and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.  

Exhibit Number	Description
99.A	Hillenbrand Industries, Inc. Investor Presentation
99.B	Batesville Holdings, Inc. Investor Presentation
99.C	Press Release dated March 13, 2008

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	HILLENBRAND INDUSTRIES, INC.
DATE: March 13, 2008	BY:	/S/ Gregory N. Miller
		Gregory N. Miller Senior Vice President and Chief Financial Officer
DATE: March 13, 2008	BY:	/S/ Richard G. Keller
		Richard G. Keller Vice President – Controller and Chief Accounting Officer

EXHIBIT INDEX
 

Exhibit Number	Description
99.A	Hillenbrand Industries, Inc. Investor Presentation
99.B	Batesville Holdings, Inc. Investor Presentation
99.C	Press Release dated March 13, 2008

EX-99.A

Exhibit 99.A

Investor Presentation Peter H. Soderberg Gregory N. Miller Blair A. Rieth, Jr. President & CEO SVP & CFO VP IR, Comm., & Brand

Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large national providers and group purchasing organizations, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements, compliance with FDA regulations, anti-trust litigation, potential exposure to product liability or other claims, failure of the Company's announced strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in the Company's business or other adverse consequences resulting from the potential separation of the Company's two operating companies, failure to realize anticipated benefits of the separation, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the period ended September 30, 2007. The Company assumes no obligation to update or revise any forward-looking statements. All financial information in the Financial Perspective section are presented on an "as adjusted" basis and exclude the effects of special charges, separation costs, antitrust litigation costs and settlements and the write-off of certain deferred taxes. Reconciliations of these "as adjusted" amounts to those in accordance with generally accepted accounting principles in the United States are included in the Appendix to this Investor Presentation.

Building a Great Business for nearly 80 years Wm. Hillenbrand Establishes Hill-Rom Hillenbrand IPO 1971 1985 Acquires SSI - Enters Therapy Surfaces Category 2005/06 New Leadership Team Formed Hill-Rom & BCC Separate Acquires NaviCare - Enters Patient Flow Acquires ARI - Enters Respiratory Care Acquires Mediq - Enters Moveable Medical Equipment 2003/04 1929 April 1, 2008 Nearly $1.5 billion revenue* 6,700 Associates Iconic brand Top 30 medical technology pure play *2008 Guidance

Today we have a balanced business By Business Segment* NA Acute International/Surgical NA Post-Acute By Product Categories Frames & Integrated Surfaces Therapy Surfaces/Sys. Architectural & Furniture Medical Equipment Management Services Health IT Respiratory Care Surgical Support Systems 64% 23% 13% * Trailing 12 months revenue through 12/31/07 By Revenue Model* Capital, Software, Services Rental 70% 30%

Frames & Integrated Surfaces Therapeutic Surfaces and Support Systems Patient Support Systems Hill-Rom Product Categories NaviCare (r) Patient Safety Suite Health Information Technology Nurse Alerts and Communication NaviCare(r) Patient Flow Respiratory Care Surgical Support Systems Therapy Delivery #1 Patient Environment #1 Patient Environment AP & Furniture Medical Equipment Management Services

....in Large & Attractive Growth Categories $6 $5 $4 $3 $2 $1 Revenue - Categories Served ($ billion) ~20% Market Opportunity 2.8 1.8 1.7 0.6 +/- 7.0 NA Post-Acute Total HRC Market Acute Care International Care **Other Opportunities Growth Rates* 5-8% 2-5% 3-6% 6-9% 4-7% *Company Estimate **Entrepreneurial Businesses: health IT, respiratory care and Surgical Support Systems = Actual HRC Revenue

Trends Driving This Market Growth = Hill-Rom Technology enables... More effective care Safer care More satisfied patients, families and caregivers Skin Breakdown Respiratory Complications Patient Falls Facility Acquired Infections Aging Population LOS Reductions Obesity Complex Co-morbidities Staff Shortages Skill Mix Pressures Staff Injury Documentation Burdens Patient Comfort Family-Centered Care "Healing Environment" New Construction & Renovation

This is more than a hospital bed... Center of Patient Care In hospitals, the bed is... the patient's home, and the most important and ubiquitous medical technology in use Protect Patient and Caregiver from Harm Wound Prevention Falls Prevention Patient Turn Assist Powered Mobility Interoperable Integrated frame and surface Onboard data reporting Connected to hospital network, 3rd party devices and other Hill-Rom technology Sophisticated 7 microprocessors 7 DC drives Elegant User Interfaces Proprietary / Intellectual Property Advanced Surfaces Hill-Rom VersaCare A.I.R.TM

.... and this is more than a mattress Clinical Impact Superior Patient Comfort Cooler & dryer Accommodates bariatric (obese) patients Financial Impact Micro-climate Management(r) Multi-zone pressure sensing Adapts to most bed frames Proprietary / Intellectual Property Wound Prevention Falls Prevention Infection Prevention Turn Assist Patient Experience CMS Non-Payment Ruling Flexible for Institutional Budgeting Asset Management Advantages Sophisticated Hill-Rom E700TM Mattress replacement

Our Strategy and Goals Successfully executing strategy introduced in October 2006

Med / Surg ICU NA Acute Care... Differentiate the Core; Revitalize Rental Business Competitive Advantages Installed base...+700,000 beds Iconic brand Strong Channel Convergence of IT & Devices Our Focus Deeper customer partnerships Patient Safety Solutions Innovation and investment in therapy systems Channel enhancements TotalCare(r) CareAssist(r) VersaCare(r) NaviCare(r) Software Solutions Stretchers Affinity (r) IV Specialty Patient Communications Patient Flow Patient Safety

Our NaviCare(r) Patient Safety Solutions Suite Potential Benefits Technology Siderail down alerts Brakes set sensor Patient pressure sensor Prevalence: 3.73 per 1000 patient days3 Cost per patient: $26,2354 Hospital Cost: ~$30,360 per bed per year7 Head Of Bed elevation monitoring Continuous Lateral Rotation Therapy Percussion / vibration therapy Prevalence: 40% of ventilated patients develop ventilator associated pneumonia (VAP)1 Cost per patient: $40,0002 Microclimate management Continuous pressure relief Nano Ag+(tm) infection control Prevalence: 2.5 million per year5 Cost per patient: $10,843 median6 Hospital Cost: ~$38,725 per bed per year7,8 Launch 8/07 1) Dodek,P.,Keenan,S., Cook, D.,Heyland,D.,et al. Annals of Internal Medicine 2004 2) Rello J, Ollendorf DA, Osler G, et al,Chest 2002 3) Dunton, Gajewski, Taunton, & Moore, Nursing Outlook 2004 4) Haumschild, Karfonta, Haumschild, Phillips, and Wilson, American Journal of Health- System Pharmacists 2003 (adjusted for inflation) 5) Institute for Healthcare Improvement estimates; WSJ 9/5/07 6) Zahn & Miller, JAMA (2003) 7) Assumes 85% bed occupancy 8) Assumes 700,000 acute care beds in U.S.; Company estimates (tm) (tm) (tm)

We have made targeted investments... NA Acute Rental Fleet Investment 2005 - $55MM 2006 - $42MM 2007 - $51MM 2008(E) - $50MM NA Acute Sales Channel Investments FY07 Headcount Expansion Territories Market Specialists MEMS Acct Mgrs. Current Headcount 280 270 260 250 240 230 220 210 200 30 280 208 8 34 Today GM 115 ACD 101 Market Specialists 30 MEMS Acct. Mgrs 34 Headcount ....to further defend and differentiate TotalCare(r) BariatricPlus Envision E700TM 8/07 11/06

Achieve a Leadership Position in NA Post-Acute Care Competitive Advantages Direct channels and customer relationships Unmatched national service and distribution capabilities Care process knowledge and technology Our Focus Fill in product line gaps Innovation and differentiation Enhance our business systems Build a Direct-to-Consumer business The Opportunity Care is migrating outside the hospital Double NA Post-Acute Care in 5 years 100 Low Bed The Vest Airway Clearance System 300 Wound Surface www.hill-rom.com 12/07 2/08 4/07

Rapidly Grow International Competitive Advantages Efficient localized manufacturing Outstanding European rental and service operations Product platform leverage Established channels ~200 sales associates and clinical specialists Our Focus Innovation and differentiation Develop European MLTC business Expand in emerging growth regions Establish Monterrey and Singapore operations AvantGuard(tm) 800 Medicalized Long-Term Care Platform AvantGuard(tm) 1600 ICU Platform Meltis(tm) Furniture 9/07 4/08 9/07

We are Taking Share Internationally 236 275 220 300 250 200 150 100 50 0 7% Growth 2005 2006 2007 2008E 17% Growth 9% - 12% Growth CAGR 11.4% Constant Currency @ 2008 plan rates 300 - 310 Revenue ($ Millions)

Product Pricing and Discounting Disciplined pricing and contracting processes LCR Sourcing / Supply Chain Rationalization We Seek Improved Gross Margins... Monterrey, MX Manufacturing 300,000 sq. ft. facility coming online now Platform Design Faster development Modularity & reuse Quality & reliability Launch Higher Margin Products Innovation commands price and margin $100M $40M 125 100 75 50 25 0 50% 40% 30% 20% 10% 0% $$ of materials spend FY06 FY09(E) % of materials spend Strategic supplier management Leverage Suzhou, China center

....especially by accelerating innovation 6.0% 5.0% 4.0% 3.0% 2.0% 1.0% 0.0% R&D Expense 2006 2007 2008(E) LTG 3.5% 4.1 - 4.3% 3.0% 5-6% Singapore Technology Ctr. Bringing world's best electronic, informatics, and processes into our solutions 10 17 24 30 25 20 15 10 5 # of Products Launched % of Revenue Hill-Rom Innovation Ctr. Co-location of project teams for innovation platforms

March 2008 Innovative silver ion technology for better infection control We are looking outward... for opportunities to add value Acquisitions that create value 2 - 4% incremental revenue CAGR via M&A Alliances to rapidly access new products, markets, and customers April 2007 July 2007 February 2008 Introduce jointly developed and branded line of comfort sleep surfaces Groundbreaking distribution alliance in Japan; development in the U.S. October 2006 Acquisition of Australian bed manufacturer IT Alliance to simplify care delivery Alliances Acquisition

We expect our separation will... 3-Year Financial Goals 6 - 8% organic revenue growth 2 - 4% incremental via M&A 400 bp gross margin Free cash flow 12-15% EPS growth 1 3 2 4 Focus management and Board on building a premium med-tech company Foster a culture of speed, accountability, & employee ownership Build heightened awareness with investors, analysts, and other stakeholders Allow optimal capital structure, and potential use of stock as currency

Financial Perspective

2002-05 CAGR: 2.0% [ (0.7%) organic] Exited the MedGas and Infant Care businesses Acquired businesses in MME, Respiratory Care and Patient Flow segments 2005-07 CAGR: 3.0% Capital + 7.7% Rental (5.7%) 2007-10 CAGR Target: 8-12% 6-8% organic 2-4% M&A Revenue Growth is Accelerating Year 1500 1400 1300 1200 1100 1000 900 800 '03 '04 '05 '06 '07 '08 (E) '02 90 188 2002-05 CAGR 2.0% Revenue ($ Millions) 1168 1189 1279 1288 1357 1427- 1476 1205 101 157 183 196 Organic Discontinued Operations M&A Range 2005-07 CAGR 3.0% LTG CAGR 8-12%

.... and Recent Quarterly Performance is Encouraging 400 350 300 250 200 150 100 321 312 2.8% Q1 335 315 6.3% Q2 329 304 8.2% Q3 372 357 4.2% Q4 341 2006 2007 2008 6.4% 321 Q1 2006-07 2007- 08 Revenue ($ Million) Growth Vs. Prior Year Q1 FY08 Trailing 12 months growth = 6.2%

Gross Margins begin to improve 2007 capital gross margin improved to 42.2% without $3.4M Mexico startup 2007 total gross margin improved to 44.7% without $3.4M Mexico startup Shifts in mix have negative impact FY2010 Target: 47-49% Capital Rental 54% 52% 50% 48% 46% 44% 42% 40% 2005 40.6% Year Total % 2006 2007 2008 (E) 52.4% 41.9% 49.0% 41.9% 50.2% 42.8% 50.8% 44.3% 52.5% 44.9% 44.2% 44.4% 45.2 - 46.8% Gross Margin

Operating Expenses Reflect Investments 2006 reflects positive Hillenbrand/Hill-Rom restructuring impact 2007 & 2008 reflect ramp of investments in R&D, sales and marketing to fuel revenue growth FY2010 Target: 36-37% of revenue 05 550 500 450 400 350 300 250 200 2005 444 Year % of Revenue 2006 2007 2008 (E) 433 482 525 553 34.7% 33.6% 35.5% 37 - 38% Operating Expenses ($ Million)

EBIT, EBITDA and Adjusted Earnings Per Share Investment ramp reflected in 2007 and 2008 Benefits accelerate in 2008 2007-10 CAGR target: 12-15% 131 121 120 137 300 250 200 150 100 50 0 247 '05 10.2% 17.7% '06 10.6% 17.7% '07 8.9% 15.5% '08 (E) 8 - 9% 16 - 17% $ Million 226 210 229 228 138 EBIT EBITDA Year EBIT % of Rev EBITDA % of Rev $1.40 $1.30 $1.20 $1.10 $1.00 $.90 $.80 $.70 $.60 $.50 '05 '06 '07 '08 (E) Year Diluted Adj. EPS from Continuing Ops $1.02 $1.35 $1.13 $1.13 -1.32

Cash Flow from Operations and Free Cash Flow Capital Deployment Priorities Re-invest into business Maintain initial dividend Strategic acquisitions Return cash to shareholders via opportunistic share repurchases 225 200 175 150 125 100 75 50 25 0 '05 $112 $8 '06 $80 $6 '07 $150 $32 '08 (E) $190-210 $75 - $95 Year CF from Ops Free Cash Flow Cash Flow ($ Million) Cash Flow from Ops Free Cash Flow

Impact of Separation on 2008 Guidance Increased Operating Expenses ( -$0.02 cents/share ) Reflects incremental amortization expense associated with equity award modification accounting Decreased Other Income and Expenses ( -$0.05 cents/share ) Reflects the allocation of Forethought and limited partnership investment and interest income moved to Batesville Casket Company, along with the paydown of debt Effective tax rate increases from 36.5% to 37.7% ( -$0.04 cents/share ) Reflects Hill-Rom specific tax items and the impact of lower Income before taxes upon separation Estimated adjusted earnings per share decreases $0.11 per share

HRC 2008 Guidance 2007 Low High Net Revenues Health Care sales 941 $991 $1,022 Health Care rentals 416 $435 $454 Total Revenues 1,357 $1,427 $1,476 vs prior year actual +5.3% +5.2% +8.8% Health Care sales gross margin % 41.9% 42.8% 44.3% Health Care rental gross margin % 50.2% 50.8% 52.5% Operating Expenses* 527 529 555 Operating Income* 121 118 133 Tax Rate 33.7% 37.7% 37.7% Income from Continuing Operations* 70 70 81 Earnings per share from Cont. Ops - GAAP $1.13 $1.11 $1.30 Earnings per share from Cont. Ops - Adj. $1.13 $1.13 $1.32 2008 Range $ millions, except per share amounts * Excludes one time charges for equity award modification and debt extinguishment costs related to the separation and that will be recognized in our second fiscal quarter of 2008.

Why Hill-Rom? Why Now? New leadership team keeping its promises...investments bearing fruit Iconic brand and large install base Business model and portfolio diversity...Much more than a bed company Growth is clearly accelerating Leverage is building...across the care continuum... around the world Separation holds real potential to unlock value

APPENDIX

Spin-off mechanics: Distribution time table The spin-off process is designed to create the best market efficiency at the time of the ultimate distribution Illustrative distribution timing Announcement date Record date Payable date Ex-date Thursday, May 10, 2007 Monday, March 24, 2008 Monday, March 31, 2008 Tuesday, April 1, 2008 Spin-off is announced No required time interval between record and payable dates Implications on when-issued time period No required time interval between record and payable dates Implications on when-issued time period Typically occurs 1 business day following the payable date for spin-offs When-issued trading period When-issued trading begins 2 days before the record date Two new securities will trade during the when-issued period in addition to Hillenbrand: Hillenbrand Ex-Distribution and Batesville When-Issued Illustrative trading dynamics When-issued Regular-way trading Limited Liquidity Normalized liquidity Stock price efficiency develops over time 3/20 3/27 4/3 4/10 4/17 4/24 5/8 6/12 6/5 5/29 5/22 5/1 5/15 Stock Price ($) Note: Graph is for illustrative purposes only. When-issued and regular way trading will not necessarily follow the pattern in the graph above.

Spin-off mechanics: Trading vehicles during when-issued During the when-issued period, investors have the opportunity to invest in three different securities Hillenbrand today Batesville Casket Hill-Rom Batesville Casket Hill-Rom Batesville Casket Hillenbrand Hillenbrand will continue to trade regular-way during the when-issued period Value of stock is reduced by the equivalent value per share of Batesville before trading commences on the Ex-Date, thereby reflecting the spin-off Settlement is regular-way T+3 Hillenbrand ex-distribution Security created by the NYSE to facilitate valuation Trading commences 2 days prior to Record Date Effectively the perceived value of Hill-Rom (i.e. Hillenbrand post Batesville spin-off at the ex-date) Trading is suspended at the end of the Payment Date, at which point Hillenbrand trades on its own (ex-Batesville) Settlement is 4 days post Payable Date Batesville when-issued Security created by the NYSE to facilitate valuation Trading commences 2 days prior to Record Date Value initially set by market maker based on research reports and order flow from investors Securities are cancelled at the close of the Payment Date, at which point Batesville trades regular-way The closing stock price on the Payment Date will be used to determine the stock price of Hillenbrand on the Ex-Date Settlement is 4 days post Payable Date Hill-Rom Note: Assumes all corporate dealings are in order. In the event that they are not, "due bills" will be used in lieu of the "ex-securities." This typically happens if the Record Date needs to occur less than 9 days from when the Board notifies the NYSE.

Reconciliation: International Revenue 2005 2006 2007 Low High International Revenue - Actual $210 $217 $271 $300 $310 F/X Adjustment to 2008 Rates 10 19 4 -- -- International Revenue - Constant Currency Basis $220 $236 $275 $300 $310 2008 Range

Reconciliation: Operating Expenses 2005 2006 2007 Low High Operating Expenses - Actual $467 $438 $483 $525 $553 Antitrust Litigation Costs 23 5 1 -- -- Operating Expenses - Adjusted $444 $433 $482 $525 $553 2008 Range

Reconciliation: EBIT and EBITDA 2005 2006 2007 Low High Income from Continuing Operations $(219) $79 $70 $70 $82 Income Tax Expense (89) 37 36 41 47 Other Income/Expense, net 23 14 15 8 8 Operating Profit (286) 129 121 118 136 Antitrust Litigation Costs 23 5 1 -- -- Litigation Charges (Credits) 359 (2) (1) -- -- Special Charges 34 5 -- 2 2 EBIT - Adjusted $131 $137 $121 $120 $138 Depreciation/Amortization 96 91 89 109 109 EBITDA - Adjusted $226 $228 $210 $229 $247 NOTE: Certain amounts may not accurately add due to rounding. 2008 Range

Reconciliation: EPS 2005 2006 2007 Low High Earnings Per Share $(3.55) $1.27 $1.13 $1.10 $1.29 Antitrust Litigation Costs 0.24 0.05 0.01 -- -- Special Charges 0.42 0.05 -- 0.02 0.02 Litigation Charges (Credits) 3.66 (0.02) (0.01) -- -- Write-off of Deferred Tax Asset 0.26 -- -- -- -- Earnings Per Share - Adjusted $1.02 $1.35 $1.13 $1.13 $1.32 NOTE: Certain amounts may not accurately add due to rounding. 2008 Range

Reconciliation: Cash Flow 2005 2006 2007 Low High Cash Flow from Operations $112 $(109) $150 $190 $210 Litigation Charge, Net of Tax -- 189 -- -- -- Cash Flow from Operations - Adjusted $112 $80 $150 $190 $210 Less: Capital Expenditures 104 74 118 115 115 Free Cash Flow $8 $6 $32 $75 $95 2008 Range

Anti-Trust Litigation Update Batesville Casket Company (BCC) sales policy: BCC has had a long-standing policy of selling caskets only to licensed funeral directors who operate licensed funeral homes. Plaintiffs allege that BCC's maintenance and enforcement of, and alleged modifications to, that policy were the product of a conspiracy among BCC and its funeral home customers to exclude "independent casket discounters" ("ICDs") from an alleged national market for the sale of caskets to consumers. ICDs are casket retailers who are not licensed funeral homes and do not offer funeral services Two cases by ICDs and consumers against: BCC and Hillenbrand Industries/Hill-Rom Holdings, together with three of BCC's large national funeral home customers Plaintiffs seek: certifications of two classes (i.e., consumers in the U.S. who purchased BCC caskets from defendant funeral homes, and U.S. ICDs), trebled monetary damages, attorneys' fees and costs, and change of BCC's sales practices. Procedurally/Substantively: Fact discovery completed Class certification hearings held in early December 2006 - still awaiting a ruling Docket call (i.e., meeting to set trial schedule) is set for May 2008; parties will likely appeal class certification ruling - could impact trial date We believe we have committed no wrongdoing as alleged We believe we have meritorious defenses to class certification and to the plaintiffs' underlying allegations and damage theories and will continue to assert those defenses vigorously We have not established a loss reserve For more information regarding the JSA, refer to the Registration Statement on Form 10 filed by Batesville Holdings.

Judgment Sharing Agreement (JSA) While we believe we have committed no wrongdoing as alleged , we concluded that it would be prudent to establish a JSA between BCC and us to predictably allocate any potential litigation exposure and maintain status quo. Expenses: BCC will pay all costs and expenses of the antitrust litigation and related cases. Damages: JSA addresses how we each fund an adverse judgment, a settlement that results in a final dismissal of BCC and HB (Hill-Rom), or a bond to stay an adverse judgment pending appeal. Maximum Funds: Each party is required to use its best efforts to raise maximum funding, with the maximization of proceeds taking precedence over the terms, credit ratings and costs, from (i) all funds on hand, except normal operating cash, (ii) additional debt as may be issued and drawn down under all credit facilities, and (iii) issuance of additional equity. Order of payments: BCC pays first because the subject of the litigation is its channel policy. BCC is required to provide the Maximum Funds available to it, minus a negotiated deductible. HB is then required to provide the Maximum Funds available to us. If required, BCC will provide the deductible. Termination: If either party is dismissed as a defendant (except as a result of a unilateral settlement) or found not liable for any damages, its funding and contribution obligations terminate. Unilateral Settlement: Either party may enter into a settlement without the consent of the other, but its obligations under the JSA continue unless the settlement includes and is agreed to by both companies For more information regarding the JSA, refer to the Registration Statement on Form 10 filed by Batesville Holdings.

EX-99.B

Exhibit 99.B

HI Kenneth A. Camp President & Chief Executive Officer Cynthia L. Lucchese Senior Vice President & Chief Financial Officer Mark R. Lanning Vice President of Investor Relations & Treasurer

Certain statements in this presentation contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: antitrust litigation, the Company's dependence on its relationships with several large national providers, continued fluctuations in mortality rates and increased cremations, whether the Company's new products are successful in the marketplace, ongoing involvement in claims, lawsuits and governmental proceedings related to operations, failure of the Company's announced strategic initiatives to achieve expected growth, efficiencies or cost reductions, disruptions in the Company's business or other adverse consequences resulting from the planned separation of Hillenbrand Industries into two operating companies, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, competition from nontraditional sources in the funeral services business, volatility of the Company's investment portfolio, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's registration statement on Form 10 initially filed with the U.S. Securities and Exchange Commission in November 2007 and as amended through the date of this presentation. The Company assumes no obligation to update or revise any forward-looking statements. Forward-looking statements

Our message Clear industry leader with unrivaled brand and 100-year heritage of innovation Unmatched distribution and manufacturing expertise provides a significant competitive advantage Enduring and strong customer relationships and strategic partnering, such as merchandising, make Batesville more than a product supplier Future industry growth due to the "graying of America" Demonstrated ability to achieve results through the death trough Margin improvement resulting from relentless focus on operational excellence Price realization offsetting declining funeral volumes Strong balance sheet, steady profitable growth and consistent cash flow available for reinvestment in strategic opportunities and capital return to shareholders Attractive investment proposition: recession-resistant industry, discounted relative to death care peers, and above-average dividend payout ratio

Past Future Business focus Part of a conglomerate focused on supporting parent company priorities Generate meaningful, stable cash flow Management and employees focused on and rewarded by building premium stand-alone company Continue to generate meaningful, stable cash flow Capital deployment Much of excess cash flow invested in health care business Excess cash flows invested in support of Hillenbrand, Inc., and shareholder value creation Investor clarity Low visibility to investment community resulting in discounted valuation relative to peers and investment fundamentals Highlight unique investment opportunity Easier-to-understand story Potential for broadened research coverage Benefits of separation to Hillenbrand, Inc.

Industry background 4

Pre-need At-need Post-need Financial instruments Funeral planning Estate planning Legacy planning Caskets Urns Remembrances Vaults Body handling (including cremation) Logistics planning Event hosting Transportation Financing Permanent memorialization (e.g. markers, monuments) Grief counseling Financial counseling = space pursued by Batesville today Funeral products ($2.4 billion industry) Batesville participates in one of the highest margin segments of the death care industry Products Services Caskets $1.3 Grave markers $0.6 Vaults $0.4 Cremation $0.1 Source: Company estimates and public filings

$11 billion funeral service industry is highly fragmented 22,000 funeral homes (U.S. and Canada), 16,000 Batesville customers Average funeral home performs ~125 calls per year Typical funeral home carries little or no product inventory Funeral homes and families dependent on casket suppliers for fast, reliable delivery Funeral home economics dependent on product sales Profit from casket mark-up 2.5 to 3.0x Batesville merchandising helps funeral homes achieve their financial objectives Caskets are core to funeral service industry dynamics Regional consolidators $0.3 Independent $8.9 National $1.8 Source: Company estimates and public filings

The current death trough most likely caused by birth trough 75 years ago Live births (millions) Driver of death trough The "graying of America" is a phenomenon that will significantly impact funeral services Dr. Vanderlyn Pine projects death trends to mirror birth rates, which will yield a "death spike" in coming years Cremations have increased slowly and steadily at an annual rate of 1.1% Increases in cremations have offset increases in deaths in recent years We have the ability to respond to increases in demand without adding any brick and mortar Future increase in deaths Cremations currently account for 34% of deaths Actual cremations Projected cremations U.S. Cremations (000s)

Batesville Casket business overview 8

We are the industry leader in caskets and cremation products Caskets (Total revenues: $1.3 billion) Cremation products (Total revenues: $100+ million) Aurora Other (200+) Matthews Batesville Aurora Other (100+) Importers Matthews Batesville Source: Company estimates and public filings

Revenue by type Regional consolidators 2% International 2% NorthStar 1% National 18% Independent 77% Revenue by customer Our breadth of customers and products provides stability and maximizes opportunities 2007 revenue = $667 million Premium metal 15% Non-gasketed & cloth 7% Cremation 6% Wood 31% Standard metal 41%

Over the years, Batesville has developed and perfected enduring competencies Points of differentiation to be leveraged Culture of execution CI / lean manufacturing Low cost Flexible Innovative Safety conscious Logistics/ distribution Strong cash flow Capabilities nationally recognized beyond the death care industry Low cost Dependable Fast Safety conscious Favorably benchmarked against FedEx, UPS 2007 cash flow from operations of $127 million, $112 million free cash flow (after CapEx) Dependable, recession-proof industry Strong track record of increasing revenue Branding Superior reputation Quality Innovation Service Industry leader and brand of choice for funeral directors' own families Successful price realization Highly effective merchandising History of successful acquisition integration Average gross revenue per unit FY '03 FY '04 FY '05 FY '06 FY '07

The power of the Batesville brand Superior products Quality Personalization Exceptional service "Right-casket, right-time" White glove delivery Leader in innovation Product design and features Merchandising for higher-value transactions Highly valued business partner Innovative services to improve and enhance the business of our customers Customer education and training Low/no customer inventory requirements (rely on us) Iconic brand with 100+ years of history Industry leader: revenue, volume, margin share Superior mix of products sold Brand of choice for funeral directors' families The promise: Unparalleled commitment to the industry The result: The world's largest casket manufacturer "Every family deserves a Batesville"

Our caskets are designed to appeal to both funeral directors and families

Batesville has the widest selection of caskets in the industry Batesville's metal and wood product lines span the entire value range with progressive designs and material types Bronze Copper Stainless Steel V A L U E R A N G E

Industry innovations (since 1940) We have been the industry trendsetter for more than 100 years ... and continue to lead in creativity and innovation 2000 1990 1980 1970 1960 1950 1940 1900 2006 ASYST(tm) Merchandising System 2005 Memory Shelf(r) feature; Funeral director website; Meaningful Memories(r) kiosk 2004 Veneer casket line; Dimensions(r) oversize line 2003 Marsellus(r) brand; Charpente(r) interior system; Meaningful Memories(r) Funeral Planner 1999 Promethean full polished bronze 1998 Memory Frame(r) panel inserts 1997 Meaningful Memories(r) display system 1996 Memory Safe(r) Drawer ; Casket engraving 1995 LifeSymbols(r) Casket Corners 1993 Options(r) cremation system 1991 Failsafe(r) liner 1989 PMP merchandising system 1985 Stainless steel casket line 1982 Insertable embroidered cap panels 1978 Product liability insurance 1977 Batesville Management Services 1976 Living Memorial(r) program 1975 Formal selection room merchandising 1974 Snap lock cap brace 1969 Auto shirred interiors 1968 First standard line of caskets 1964 Swing bar hardware 1963 Insured warranty 1962 Vacuum hardware plating 1958 Cathodic protection 1957 First metal braces; Lift and tilt bed 1954 Memorial Record(tm) Tube 1946 One-piece form top design 1940 First gasketed metal casket - The Monoseal(tm)

Relentless focus on continuous improvement drives cost reductions year after year World-class manufacturing modeled on Toyota lean manufacturing system Seven manufacturing facilities in the U.S. and Mexico High-velocity mixed model, pull production, one-piece flow system resulting in lower levels of finished goods inventory Continuous improvement a way of life. Motto: "Creativity before capital" Experienced and empowered workforce Award winning manufacturing operations - IndustryWeek & AME Operations conversion cost per unit Gross dollars deflated by producer price index-finished goods Over the last 5 years our real labor costs have declined 6.1% annually Source: U.S. Department of Labor, Bureau of Labor Statistics

Oklahoma City "Right-casket, right-time" delivery 99.3% on-time delivery Daily delivery to 65+% of our customers 650 specially equipped vehicles Our high-velocity distribution system delivers unmatched service to our customers Manchester Knoxville Hendersonville Louisville Eddyville Nashville Charleston Moncton Bismarck Seattle Spokane Portland Omaha Minneapolis Denver Kansas City Abilene San Antonio Houston Des Moines Green Bay Milwaukee Carlock St. Louis Grand Rapids Detroit Norwalk Warsaw Indianapolis Cincinnati Columbus Memphis Birmingham Atlanta Charlotte Goldsboro Ft. Lauderdale Orlando Jacksonville Hammond Shreveport Little Rock Woonsocket Maine Hartford Albany Syracuse Rochester Buffalo Pittsburgh Baltimore Petersburg Roanoke Long Island New York Moonachie Wall Township Montreal Toronto Winnipeg Saskatoon Edmonton Calgary Vancouver Miami Tulsa Salt Lake Albuquerque Phoenix San Diego Fresno Hayward Sacramento Los Angeles Fullerton Las Vegas Chicago Dallas Lansdale Allentown Lakeland Rapid deployment centers 6 rapid deployment centers 88 customer service centers

We are much more than a product supplier to our customer partners Customer visit and educational programs Customized display systems Merchandising and business practice consulting Technology solutions: Web design & hosting / kiosks

Merchandising enables us to optimize the value of every funeral Customer merchandising increases our revenue per unit 9% 20% 4% 0% 10% 20% 30% Templates only Templates plus ASYST Templates plus ASYST plus Info Center Customer revenue growth from effective merchandising date Triple win Consumers: increased satisfaction Customers: increased revenue & profit Batesville: increased revenue & profit Current penetration 15% 7% 1% Revenue grows as customers implement more elements

We have achieved an increasing revenue growth rate despite the death trough Death CAGR: 0.3% Revenue CAGR: 2.3% $ in mil # of U.S. deaths in mil .... and we are uniquely positioned to meet increases in market demand Midpoint

Successful acquisition history in an industry with potential for continued consolidation 6 selective acquisitions over the past 15 years (casket distributors) Generally less than $10m in size Ability to integrate with minimal fixed cost investment results in attractive returns Attractive IRRs (in excess of 20%) for each acquisition Disciplined integration process key to success Focus on customer retention Improve mix of products sold Deliver efficiencies by leveraging current infrastructure Lakeshore Casket Company case study Date acquired January 2007 Year 1 incremental gross revenues $6m Purchase price $5m Increase in average wholesale price per unit 15% IRR >30%

Strategy and management team 22

Our strategic actions are designed to build upon existing strengths and create new ones Defend the core and grow organically Selective tuck-in acquisitions in the casket industry Drive shareholder value New business development in adjacent death care segments Leverage core competencies

The future: Drive revenue and earnings growth Top-line growth Demonstrated ability to achieve results through the death trough Poised to capitalize on "graying of America" Raise the value of every casket sale through merchandising programs Leverage strong customer relationships and premium brand through focused sales coverage Continue tradition of selective acquisitions of casket distributors Margin improvement Relentless focus on operational excellence, lean manufacturing, and CI A stand-alone imperative to grow Build on premium brand and reputation Capitalize on strong manufacturing and distribution capabilities Accelerate investments in growth initiatives

Strong leadership team with deep industry and public company experience Name Years of experience Previous experience Ken Camp President & CEO, HI 27 years experience with Batesville Casket and Hillenbrand Industries President & Chief Executive Officer, Batesville Casket, & Senior Vice President, Hillenbrand Industries Vice President, Administration, Hillenbrand Industries Vice President & General Manager, Operations, Batesville Casket Vice President, Sales & Service, Batesville Casket Vice President, Marketing, Batesville Casket Vice President, Strategic Planning, Batesville Casket Cindy Lucchese Sr. VP & CFO, HI 20+ years public company, executive and financial management experience Senior Vice President & Chief Financial Officer, Thoratec Corporation Vice President & Treasurer; Vice President & Chief Accounting Officer; Vice President, Finance, Sales Division, Guidant Corporation Various financial management roles, Eli Lilly and Company John Zerkle Sr. VP, Gen. Counsel & Secretary, HI 4 years Batesville Casket experience; 20+ years private law practice Vice President & General Counsel, Batesville Casket Vice President & General Counsel, Forethought Financial Services Senior Partner, Leagre Chandler & Millard, LLP Mike DiBease Vice President, Marketing, Batesville Casket Company 30 years experience with Batesville Casket Company Vice President, Sales, Batesville Casket Vice President, Strategic Accounts, Batesville Casket Divisional Vice President, Sales, Batesville Casket Mark English Vice President, Global Sales, Batesville Casket Company 19 years experience with Batesville Casket and Hillenbrand Industries Vice President, Sales, East Division, Batesville Casket Vice President, Strategy & Planning, Batesville Casket Executive Director, Field Service Operations, Hill-Rom Executive Director, Continuous Improvement, Field Services, Hill-Rom Doug Kunkel Vice President, Global Supply Chain, Batesville Casket Company 15 years experience with Batesville Casket and Hillenbrand Industries; 6 years public accounting Vice President, Operations, Batesville Casket Vice President, Chief Financial Officer, Batesville Casket Vice President & Controller, Hill-Rom Director of International & Financial Planning, Hill-Rom

Legal and financial review 26

Anti-trust litigation update Batesville Casket Company (BCC) sales policy: BCC has had a long-standing policy of selling caskets only to licensed funeral directors who operate licensed funeral homes. Plaintiffs allege: that BCC's maintenance and enforcement of, and alleged modifications to, that policy were the product of a conspiracy among BCC and its funeral home customers to exclude "independent casket discounters" ("ICDs"*) from an alleged national market for the sale of caskets to consumers. Two cases by ICDs and consumers against: BCC and Hillenbrand Industries/Hill-Rom Holdings, together with three of BCC's large national funeral home customers Plaintiffs seek: certifications of two classes (i.e., consumers in the U.S. who purchased BCC caskets from defendant funeral homes, and U.S. ICDs), trebled monetary damages, attorneys' fees and costs, and change of BCC's sales practices. Procedurally/Substantively: Fact discovery completed Class certification hearings held in early December 2006 - still awaiting a ruling Docket call (i.e., meeting to set trial schedule) is set for May 2008; parties will likely appeal class certification ruling - could impact trial date We believe we have committed no wrongdoing as alleged We believe we have meritorious defenses to class certification and to the plaintiffs' underlying allegations and damage theories and will continue to assert those defenses vigorously We have not established a loss reserve * ICDs are casket retailers who are not licensed funeral homes and do not offer funeral services.

Judgment sharing agreement (JSA) While we believe we have committed no wrongdoing as alleged, we concluded that it would be prudent to establish a JSA between Hillenbrand Industries/Hill-Rom Holdings (HRC) and us to predictably allocate any potential litigation exposure and maintain status quo. Expenses: Hillenbrand, Inc./Batesville Casket Company (HI) will pay all costs and expenses of the antitrust litigation and related cases. Damages: JSA addresses how we each fund an adverse judgment, a settlement that results in a final dismissal of HRC and us, or a bond to stay an adverse judgment pending appeal. Maximum Funds: Each party is required to use its best efforts to raise maximum funding, with the maximization of proceeds taking precedence over the terms, credit ratings and costs, from (i) all funds on hand, except normal operating cash, (ii) additional debt as may be issued and drawn down under all credit facilities, and (iii) issuance of additional equity. Order of payments: HI pays first because the subject of the litigation is Batesville Casket Company's channel policy. We are required to provide the Maximum Funds available to us, minus a negotiated deductible. HRC is then required to provide the Maximum Funds available to them. If required, HI will provide the deductible. Termination: If either party is dismissed as a defendant (except as a result of a unilateral settlement) or found not liable for any damages, its funding and contribution obligations terminate. Unilateral Settlement: Either party may enter into a settlement without the consent of the other, but its obligations under the JSA continue unless the settlement includes and is agreed to by both companies

History of stable revenue and gross margin ... Revenue Gross margin * % of revenue * Includes distribution costs Range Range

.... translating into strong operating results Operating expenses Operating profit (% of revenue) Diluted earnings per share Free cash flow* * Note: Historical '04 - '07 amounts are combined results from Batesville Holdings. Please see Form 10 as amended for further details. Midpoint Midpoint Midpoint Midpoint * Cash from operations less capital expenditures $44 mil pension funding

High dividend relative to peers Initial annual dividend payment will be $0.73 per share and approximate a payout ratio of 40% of annualized 2008 net income Intent to grow dividend more slowly than earnings growth to bring dividend payout levels in line with peers Maintain investment-grade rating Initial rating expected to be investment-grade: BBB/Baa2 Cash flow from operations Capital deployment strategy focuses on creating shareholder value ~20% invested in working capital & capital ex ~40% returned to shareholders via dividends ~40% invested in ongoing business development, acquisitions, share repurchase, and debt repayment Return on net assets * * Computed utilizing Batesville Casket segment data

Hillenbrand, Inc., 2008 guidance * Separation expenses estimated to be $16m to $18m in 2008.

Separation can spur unlocking value Clear industry leader with unrivaled brand and 100-year heritage of innovation Unmatched distribution and manufacturing expertise provides a significant competitive advantage Enduring and strong customer relationships and strategic partnering, such as merchandising, make Batesville more than a product supplier Future industry growth due to the "graying of America" Demonstrated ability to achieve results through the death trough Margin improvement resulting from relentless focus on operational excellence Price realization offsetting declining funeral volumes Strong balance sheet, steady profitable growth and consistent cash flow available for reinvestment in strategic opportunities and capital return to shareholders Attractive investment proposition: recession-resistant industry, discounted relative to death care peers, and above-average dividend payout ratio

Appendix Spin-off mechanics 34

Spin-off mechanics: Distribution time table The spin-off process is designed to create the best market efficiency at the time of the ultimate distribution Illustrative distribution timing Announcement date Record date Payable date Ex-date Thursday, May 10, 2007 Monday, March 24, 2008 Monday, March 31, 2008 Tuesday, April 1, 2008 Spin-off is announced No required time interval between record and payable dates Implications on when-issued time period No required time interval between record and payable dates Implications on when-issued time period Typically occurs 1 business day following the payable date for spin-offs When-issued trading period When-issued trading begins 2 days before the record date Two new securities will trade during the when-issued period in addition to Hillenbrand: Hillenbrand Ex-Distribution and Batesville When-Issued Illustrative trading dynamics When-issued Regular-way trading Limited Liquidity Normalized liquidity Stock price efficiency develops over time 3/20 3/27 4/3 4/10 4/17 4/24 5/8 6/12 6/5 5/29 5/22 5/1 5/15 Stock Price ($) Note: Graph is for illustrative purposes only. When-issued and regular way trading will not necessarily follow the pattern in the graph above.

Spin-off mechanics: Trading vehicles during when-issued During the when-issued period, investors have the opportunity to invest in three different securities Hillenbrand today Batesville Casket Hill-Rom Batesville Casket Hill-Rom Batesville Casket Hillenbrand Industries Hillenbrand will continue to trade regular-way during the when-issued period Value of stock is reduced by the equivalent value per share of Batesville Holdings before trading commences on the ex-date, thereby reflecting the spin-off Settlement is regular-way T+3 Hillenbrand Industries ex-distribution Security created by the NYSE to facilitate valuation Trading commences 2 days prior to record date Effectively the perceived value of Hill-Rom (i.e. Hillenbrand post Batesville Holdings spin-off at the ex-date) Trading is suspended at the end of the payment date, at which point Hillenbrand trades on its own (ex-Batesville) Settlement is 4 days post payable date Batesville Holdings/Hillenbrand, Inc., when-issued Security created by the NYSE to facilitate valuation Trading commences 2 days prior to record date Value initially set by market maker based on research reports and order flow from investors Securities are cancelled at the close of the payment date, at which point Hillenbrand, Inc., trades regular-way The closing stock price on the payment date will be used to determine the stock price of Hillenbrand on the ex-date Settlement is 4 days post payable date Hill-Rom Note: Assumes all corporate dealings are in order. In the event that they are not, "due bills" will be used in lieu of the "ex-securities." This typically happens if the record date needs to occur less than 9 days from when the Board notifies the NYSE. Batesville Holdings

EX-99.C

Exhibit 99C

CONTACT INFORMATION

Investor Relations
Contact:	Blair A. (Andy) Rieth, Jr., Vice President, Investor Relations, Corporate Communications & Global Brand Development
Phone:	812-931-2199
Email:	andy.rieth@hillenbrand.com
Media Contact:	Lauren Green-Caldwell, Director, Corporate Communications & Public Relations
Phone:	812-934-8692
Email:	lauren.green-caldwell@hillenbrand.com

HILLLENBRAND RELEASES INVESTOR ROADSHOW MATERIALS AND
UPDATED FINANCIAL GUIDANCE RELATED TO SEPARATION
OF HILL-ROM AND BATESVILLE CASKET

Operating Financial Guidance Remains Unchanged and is Updated to Reflect
On-going Public Company and Other Costs and Tax Rate Effects of Separation

BATESVILLE, Ind., March 13, 2008 — Hillenbrand Industries, Inc. (NYSE: HB) filed materials with the Securities and Exchange Commission (SEC) associated with investor communications related to the upcoming separation of its two operating companies: Hill-Rom, the company’s medical technology business, and Batesville Casket, the company’s death care business. The separation is expected to be completed by the end of March pending final clearance of the Form 10 of Batesville Holdings, Inc., to be the parent company for Batesville Casket, originally filed November 5, 2007 and last amended on March 13, 2008, and other conditions listed below.

A Form 8-K filing, consisting of presentation materials for each company, is posted on the SEC website at www.sec.gov and also can be viewed on the Hillenbrand website at www.hillenbrand.com.

FINANCIAL GUIDANCE SUMMARY FOR FY 2008

In order to provide investors additional financial information with respect to Hill-Rom and Batesville on a post-separation basis, our existing operational guidance has been supplemented to reflect future expectations for the balance of fiscal 2008 for each business. Updated financial guidance for both businesses is provided in schedules accompanying this release and in the presentation materials referenced above.

For fiscal year 2008, Hill-Rom Holdings, which will be the new name of Hillenbrand Industries following the separation, continues to expect revenue of $1.427 — 1.476 billion. Capital sales are expected to be in the range of $0.991 — 1.022 billion while Hill-Rom rental revenues are expected to be between $435 — 454 million. Hill-Rom projects GAAP earnings per fully diluted share of $1.11 — 1.30, with adjusted earnings per fully diluted share of $1.13 — 1.32. These amounts have been adjusted from previously provided guidance to reflect the impacts of Hill-Rom’s new capital structure on interest expense and to eliminate other income associated with the transfer of certain investments to Batesville in conjunction with the separation. The effective tax rate has also been adjusted to give effect to the separation, along with the expiration of the research and development tax credit earlier this year. It is important to note that the above earnings guidance, both on a GAAP and as adjusted basis, exclude the effects of certain one-time costs associated with the separation, including the modification of equity compensation awards, costs associated with the repurchase of Hillenbrand debt contemplated in the transaction and other separation-related costs. These costs have been excluded due to the difficulty in predicting such amounts and the fact that many of these costs will be reflected as a component of discontinued operations in Hill-Rom’s future reporting.

Batesville Holdings, Inc, to be the parent company of Batesville Casket, will change its name to Hillenbrand, Inc. in connection with the separation. For fiscal year 2008, Batesville continues to expect revenue of $668 — 686 million, with GAAP earnings per fully diluted share of $1.27 — 1.47, and adjusted fully diluted earnings per share of $1.64 — 1.79. Adjusted fully diluted earnings exclude the effects of the anticipated equity compensation modification and other separation-related costs estimated to be $16 — 18 million (pre-tax) and anti-trust litigation costs in 2008.

All current and potential investors are encouraged to review the Disclosure Regarding Forward-Looking Statements in this press release as well as all financial documents filed by Hillenbrand Industries or its subsidiaries with the SEC. Hillenbrand Industries, Inc. provides earnings per share guidance on an adjusted basis from continuing operations because the company’s management believes that the presentation provides useful information to investors. Among other things, it may assist investors in evaluating the company’s operations period over period — which is also the basis on which it generally is most reasonable to forecast results. This measure may exclude such items as strategic developments (including restructurings and product line changes) and significant litigation. Special items may be highly variable, difficult to predict, and of a size that sometimes have substantial impact on the company’s reported operations for a period. Often, prospective quantification of them is not feasible. Management uses these measures internally for planning, forecasting and evaluating the performance of the business, including allocating resources and evaluating results relative to employee performance compensation targets. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

As previously announced, the separation also remains subject to the final approval of the Board of Directors, favorable market conditions, effectiveness of the Form 10 registration statement with the SEC, and other customary conditions. As previously disclosed, the company has already received a favorable tax ruling from the U.S. Internal Revenue Service (IRS).

ABOUT HILLENBRAND INDUSTRIES, INC.

Hillenbrand Industries is organized into two operating companies serving the health care and funeral services industries.

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and information technology solutions. Hill-Rom’s comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom...enhancing outcomes for patients and their caregivers.

Batesville Casket Company is a leader in the North American death care industry through the sale of funeral services products, including burial caskets, cremation caskets, containers and urns, selection room display fixturing and other personalization and memorialization products.

Batesville Casket Company...helping families honor the lives of those they love.

www.hillenbrand.com

Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding Hillenbrand’s, Hill-Rom’s, and Batesville’s future plans, objectives, beliefs, expectations, representations and projections. Hillenbrand has tried, wherever possible, to identify these forward-looking statements using words such as “intend,” “anticipate,” “believe,” “plan,” “encourage,” “expect,” “may,” “goal,” “become,” “pursue,” “estimate,” “strategy,” “will,” “projection,” “forecast,” “continue,” “accelerate,” “promise,” “increase,” “higher,” “lower,” “reduce,” “improve,” “expand,” “progress,” “potential” or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward-looking statements are not guarantees of future performance, and actual results could differ materially from those set forth in any forward-looking statements.

Factors that could cause Hill-Rom’s actual results to differ from forward-looking statements include but are not limited to: Hill-Rom’s dependence on its relationships with several large group purchasing organizations, whether Hill-Rom’s new products are successful in the marketplace, changes in customers’ Medicare reimbursements, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of Hill-Rom’s announced strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in Hill-Rom’s business or other adverse consequences resulting from the planned separation of Hillenbrand’s two operating companies, failure to realize the anticipated benefits of the separation, failure of Hill-Rom to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause Hill-Rom’s actual results to differ from those contained in forward-looking statements, see the discussions under the heading “Risk Factors” in Hillenbrand’s Annual Report on Form 10-K for the period ended September 30, 2007. The Company assumes no obligation to update or revise any forward-looking statements.

Factors that could cause Batesville’s actual results to differ from forward-looking statements include but are not limited to: Batesville’s dependence on its relationships with several large national providers, changes in death rates, whether Batesville’s new products are successful in the marketplace, antitrust litigation, potential exposure to product liability or other claims, failure of Batesville’s announced strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in Batesville’s business or other adverse consequences resulting from the planned separation of Hillenbrand’s two operating companies, failure to realize anticipated benefits of the separation, failure of Batesville to execute its acquisition strategy through the consummation and successful integration of acquisitions, competition from nontraditional sources in the funeral services business, volatility of Batesville’s investment portfolio, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause Batesville’s actual results to differ from those contained in forward-looking statements, see the discussions under the heading “Risk Factors” in the Registration Statement on Form 10 filed by Batesville Holdings, Inc with the SEC.

None of Hillenbrand, Hill-Rom and Batesville assumes any obligation to update or revise any forward-looking statements.

Hill-Rom Holdings (HRC) FY 2008 Financial Guidance

Guidance for 2008

($ in millions, except EPS)	Low			High
Net Revenues
Health Care sales	$	991		$	1,022
Health Care rentals		435			454
Total revenues		1,427			1,476
Health Care sales gross margin %		42.8	%		44.3	%
Health Care rentals gross margin %		50.8	%		52.5	%
Other Operating Expenses		(525	)		(553	)
Special Charges		(2	)		(2	)
Operating Income		118			136
OIE		(8	)		(8	)
Income Before Taxes	$	110		$	128
Tax Rate		37.7	%		37.7	%
Income from Continuing Operations	$	70		$	81
Earnings per share from Continuing Operations — GAAP	$	1.11		$	1.30
Special Charges		0.02			0.02
Earnings per share from Continuing Operations — Adjusted	$	1.13		$	1.32
Average shares outstanding — diluted		62.9			62.9
Capital expenditures and intangibles				$	115
Depreciation and amortization				$	109

Note 1 — certain amounts may not accurately add due to rounding
Note 2 — Excludes one-time charges for stock compensation modification, debt repurchase fees, and transaction costs

Batesville Casket FY 2008 Financial Guidance

Guidance for 2008
($ in millions, except per share amounts)	Low			High
Net revenues	$	668		$	686
Income before taxes	$	131		$	149
Tax rate		38.7	%		38.1	%
Net income — GAAP	$	80		$	93
Diluted net income per share — GAAP	$	1.27		$	1.47
Excluding non-recurring charges (anti-trust and separation expenses*)
Net income — Adjusted	$	103		$	113
Diluted net income per share — Adjusted	$	1.64		$	1.79

• Separation expenses estimated to be $16m to $18m in 2008.